Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Claire Gallois, Marine Sroussi, Thierry André, Sophie Mouillet-Richard, Natacha Agueeff, et al.. Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials. Journal of Clinical Oncology, 2025, ⟨10.1200/jco.23.02262⟩. ⟨hal-04955616⟩
-
-
-
-
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
-
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, et al.. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 2024, 16 (3), pp.315. ⟨10.3390/pharmaceutics16030315⟩. ⟨hal-04626840⟩
-
Alexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, Julien Henry, Thierry Lazure, et al.. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature. JBMR Plus, 2024, 8 (5), pp.ziae043. ⟨10.1093/jbmrpl/ziae043⟩. ⟨hal-04626829⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
Mots clés
Treatment
Crizotinib
Radiofrequency ablation
Surgical excision
Anti-CTLA-4
Polyomavirus
Molecular targeted therapies
Radiotherapy
Sonic Hedgehog
Abscopal effect
Immunothérapie
Langerhans cell histiocytosis
Amgen
Prevention
Circulating cell-free DNA
Safety
Angiosarcoma
Resistance
HIV
Metastatic cSCC
Plasma
Diagnosis
Immunohistochemistry
Chemotherapy
ALK
Colon cancer
Anti-Tumor pharmacology
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Targeted therapy
Cutaneous squamous cell carcinoma
Antibody-drug conjugate
Cancer
AML
COVID-19
Merkel cell carcinoma
Dabrafenib
Adjuvant
Allelic imbalance
Follow-up
Systemic therapy
TNM classification
Adjuvant therapy
AZD9291
Immune checkpoint inhibitor
Cemiplimab
Abdominal pain
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Immunotherapy
Anti-PD-1
Lung cancer
Anti-PD1 blockade
Adverse events
Anti-PD1
Prognosis
ADN tumoral circulant
Histiocytosis
BRAFV600E mutation
Children
Prognostic
Mesenchymal stromal cells
Survival
Toxicity
Cancer bronchique non à petites cellules
Colorectal carcinoma
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
Advanced melanoma
Circulating tumor DNA
Metastatic
BRAF
Anti-PD-1 antibody
Invasive cutaneous squamous cell carcinoma
BRAF V600E
Liver metastases
Accommodations
Non-small cell lung cancer
Adjuvant FOLFOX
Thrombosis
Trametinib
2-chlorodeoxyadenosine
Osimertinib
ACTH
Gastric bypass
ALK rearrangement
Biomarkers
EGFR
Acute generalized exanthematous pustulosis
Locally advanced
Oncology
Nivolumab
Advanced
Wnt
ADAMTS13
Melanoma
Staging
Immunomodulation
Chemoresistance
Lung adenocarcinoma
Androgen insensitivity
Colorectal cancer
Biomarker